1. Home
  2. INAB vs MOVE Comparison

INAB vs MOVE Comparison

Compare INAB & MOVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo IN8bio Inc.

INAB

IN8bio Inc.

HOLD

Current Price

$1.99

Market Cap

10.6M

Sector

Health Care

ML Signal

HOLD

Logo Movano Inc.

MOVE

Movano Inc.

HOLD

Current Price

$7.81

Market Cap

8.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
INAB
MOVE
Founded
2016
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
10.6M
8.9M
IPO Year
2021
2021

Fundamental Metrics

Financial Performance
Metric
INAB
MOVE
Price
$1.99
$7.81
Analyst Decision
Strong Buy
Analyst Count
2
0
Target Price
$108.00
N/A
AVG Volume (30 Days)
653.6K
147.0K
Earning Date
11-06-2025
03-19-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$500,000.00
Revenue This Year
N/A
$1,460.71
Revenue Next Year
N/A
$96.77
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.17
$4.67
52 Week High
$12.53
$62.80

Technical Indicators

Market Signals
Indicator
INAB
MOVE
Relative Strength Index (RSI) 59.88 46.86
Support Level $1.17 $7.01
Resistance Level $1.87 $12.08
Average True Range (ATR) 0.19 1.18
MACD 0.02 -0.17
Stochastic Oscillator 95.05 18.93

Price Performance

Historical Comparison
INAB
MOVE

About INAB IN8bio Inc.

IN8bio Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of gamma-delta T cell product candidates for solid and liquid tumors, by employing allogeneic, autologous, and genetically modified gamma-delta T cells. Its product candidates include INB-400, for the treatment of newly diagnosed glioblastoma, or GBM, INB-100 for the treatment of patients with high-risk leukemias undergoing hematopoietic stem cell transplantation, and other product candidates such as INB-200, INB-300, and INB-500.

About MOVE Movano Inc.

Movano Inc is developing a platform to deliver purpose-driven healthcare solutions to bring medical-grade, high-quality data to the forefront of consumer health devices. its initial commercial product in development is the Evie Ring, a wearable designed specifically for women. The Evie Ring combines health and wellness metrics to give a full picture of one's health, which includes resting heart rate, heart rate variability (HRV), blood oxygen saturation (SpO2), respiration rate, skin temperature variability, period and ovulation tracking, menstrual symptom tracking, activity profile, including steps, active minutes and calories burned, sleep stages and duration, and mood tracking.

Share on Social Networks: